Walpar Nutrition — 360° view

Walpar Nutrition, a company in the Pharmaceuticals industry, reported revenue of ₹41 crore and net profit of ₹1.74 crore for the September 2026 quarter.

Walpar Nutrition (NSE: WALPAR-SM) closed at ₹20.90 on 20 Nov 2026, down 49.8% over the past year. Its market capitalisation is ₹20 crore and it trades at 8.1 times earnings.

Share price
₹20.90 (20 Nov 2026)
Market cap
₹20 Cr (20 Nov 2026)
P/E
8.08 (20 Nov 2026)
Revenue
₹41 Cr (September 2026 quarter)
Net profit
₹2 Cr (September 2026 quarter)
ROCE
14.8% (FY26)
ROE
13.9% (FY26)
Book value
₹21.7 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹50.60 / ₹20.50 (20 Nov 2026)
1-year return
-49.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: WALPAR-SM

Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.